IBDEI12Z ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19075,0)
 ;;=290.40^^105^1227^32
 ;;^UTILITY(U,$J,358.3,19075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19075,1,4,0)
 ;;=4^290.40
 ;;^UTILITY(U,$J,358.3,19075,1,5,0)
 ;;=5^Dementia, Multi-Infarct
 ;;^UTILITY(U,$J,358.3,19075,2)
 ;;=^303487
 ;;^UTILITY(U,$J,358.3,19076,0)
 ;;=290.0^^105^1227^34
 ;;^UTILITY(U,$J,358.3,19076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19076,1,4,0)
 ;;=4^290.0
 ;;^UTILITY(U,$J,358.3,19076,1,5,0)
 ;;=5^Dementia, Senile
 ;;^UTILITY(U,$J,358.3,19076,2)
 ;;=^31703
 ;;^UTILITY(U,$J,358.3,19077,0)
 ;;=780.4^^105^1227^110
 ;;^UTILITY(U,$J,358.3,19077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19077,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,19077,1,5,0)
 ;;=5^Vertigo
 ;;^UTILITY(U,$J,358.3,19077,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,19078,0)
 ;;=345.90^^105^1227^105
 ;;^UTILITY(U,$J,358.3,19078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19078,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,19078,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,19078,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,19079,0)
 ;;=355.1^^105^1227^75
 ;;^UTILITY(U,$J,358.3,19079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19079,1,4,0)
 ;;=4^355.1
 ;;^UTILITY(U,$J,358.3,19079,1,5,0)
 ;;=5^Meralgia Paresthetica
 ;;^UTILITY(U,$J,358.3,19079,2)
 ;;=^265141
 ;;^UTILITY(U,$J,358.3,19080,0)
 ;;=340.^^105^1227^83
 ;;^UTILITY(U,$J,358.3,19080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19080,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,19080,1,5,0)
 ;;=5^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,19080,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,19081,0)
 ;;=729.2^^105^1227^84
 ;;^UTILITY(U,$J,358.3,19081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19081,1,4,0)
 ;;=4^729.2
 ;;^UTILITY(U,$J,358.3,19081,1,5,0)
 ;;=5^Neuropathic Pain
 ;;^UTILITY(U,$J,358.3,19081,2)
 ;;=Neuropathic Pain^82605
 ;;^UTILITY(U,$J,358.3,19082,0)
 ;;=053.19^^105^1227^92
 ;;^UTILITY(U,$J,358.3,19082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19082,1,4,0)
 ;;=4^053.19
 ;;^UTILITY(U,$J,358.3,19082,1,5,0)
 ;;=5^Post-Herpetic Neuralgia
 ;;^UTILITY(U,$J,358.3,19082,2)
 ;;=^266544
 ;;^UTILITY(U,$J,358.3,19083,0)
 ;;=310.9^^105^1227^85
 ;;^UTILITY(U,$J,358.3,19083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19083,1,4,0)
 ;;=4^310.9
 ;;^UTILITY(U,$J,358.3,19083,1,5,0)
 ;;=5^Organic Brain Syndrome
 ;;^UTILITY(U,$J,358.3,19083,2)
 ;;=^123952
 ;;^UTILITY(U,$J,358.3,19084,0)
 ;;=332.0^^105^1227^88
 ;;^UTILITY(U,$J,358.3,19084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19084,1,4,0)
 ;;=4^332.0
 ;;^UTILITY(U,$J,358.3,19084,1,5,0)
 ;;=5^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,19084,2)
 ;;=Parkinson's Disease^304847
 ;;^UTILITY(U,$J,358.3,19085,0)
 ;;=250.60^^105^1227^89
 ;;^UTILITY(U,$J,358.3,19085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19085,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,19085,1,5,0)
 ;;=5^Peripheral Neuropathy, Diabetic
 ;;^UTILITY(U,$J,358.3,19085,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,19086,0)
 ;;=356.9^^105^1227^91
 ;;^UTILITY(U,$J,358.3,19086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19086,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,19086,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,19086,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,19087,0)
 ;;=780.2^^105^1227^106
 ;;^UTILITY(U,$J,358.3,19087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19087,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,19087,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,19087,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,19088,0)
 ;;=724.3^^105^1227^102
 ;;^UTILITY(U,$J,358.3,19088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19088,1,4,0)
 ;;=4^724.3
 ;;
 ;;$END ROU IBDEI12Z
